BEGIN:VCALENDAR PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN VERSION:2.0 BEGIN:VEVENT DESCRIPTION:RNA therapeutics is a rapidly expanding industry with increasi ngly growing potential for immunotherapy\, personalised medicines\, and t reatment of genetic\, infectious\, and chronic diseases. This is reflecte d with the value of the global antisense &\; RNA therapeutics market e xpected to reach USD 1.81 billion by 2025\, growing at a CAGR of 7.5%. Wi th Covid-19 rapidly accelerating the RNA landscape through massive regula tory successes\, the recent advent of CRISPR\, an RNA-guided gene-editing technology\, as well as new strides in the delivery of messenger RNA tra nscribed in vitro\, there has been considerable progress in the developme nt of RNA medicines and a major expansion of the RNA-therapeutics field.\ n\nIn 2023 we will see the return of SAE’s RNA Therapeutics conference to a live in-person event\, showcasing an update on mRNA therapeutic applic ations\, coupled with an industry outlook of the field. We will also expl ore the latest trends in novel RNA therapies\, including developments in AI modelling and small molecule modulation of RNA. Further topics to be e xamined comprise of novel RNA modalities encompassing self-amplifying RNA \, saRNA\, circular RNA\, lnc RNA and many more.\n\nDon't miss this unmis sable opportunity to network with the pharma and biotech community of glo bal experts in the UK and Europe\; the two-day agenda offers you peer-to- peer networking with Directors of novel RNA therapies\, CEOs\, Senior and expert scientists\, Chief Medical Officers\, Senior Vice Presidents and many more.\n\n \;\n\nBenefits of attending:\n\n\nExplore how mRNA lea ds the way in the genetic medicine space as the next generation of novel drug modalities\nInvestigate the latest trends in AI drug discovery as a tool for designing novel RNA based therapeutics\nEnhance your knowledge o f the latest innovations in RNA application and RNA delivery techniques w ith case studies from BioNTech\, Neuway Pharma and Ethris GmbH\nEngage in the growing advances and development of novel RNA molecules in the treat ment of chronic respiratory\, neurodegenerative\, and infectious diseases \n\nWho should attend:\n\n\nDirectors of novel RNA therapies\nCEOs\nSenio r and expert scientists\nChief Medical Officers\nChief Technical Officers \nSenior Vice Presidents\nGlobal Heads of mRNA R&\;D\nGlobal Medical D irectors\nHeads of Translational Medicine\nDirector\, Clinical Pharmacolo gy\nGlobal Head of RNA and Targeted Therapeutics\nClinical Science Direct or\nHead of Biology\nDirector\, Genetic Medicine\nAssociate Director\n\n& nbsp\;\n\nEARLY-BIRD RATES:\n\n\nBOOK BY 31ST OCTOBER AND SAVE £400\nBOOK BY 3OTH NOVEMBER AND SAVE £200\nBOOK BY 16TH DECEMBER AND SAVE £100\n\n& nbsp\;\n\n \;\n\nAdditional Contact Info:\n\nT: +44 (0)20 7827 6732\n \nE: lamprini.balasi@saemediagroup.com\n\n \;\n\nLinkedIn: SAE Media Group Pharma\n\nTwitter: @SAEMGPharma | #RNATx2023\n DTEND:20230209T170000 DTSTAMP:20260512T232946Z DTSTART:20230208T090000 LOCATION:London\, UK\, SEQUENCE:0 SUMMARY:RNA therapeutics is a rapidly expanding industry with increasingly growing potential for immunotherapy\, personalised medicines\, and treat ment of ge... UID:384a10a0-c845-4e5c-83a4-8a3521be9762 END:VEVENT END:VCALENDAR